Recruitment

Recruitment Status
Completed
Estimated Enrollment
20

Inclusion Criteria

Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house intensive care unit
Age > 18yrs and < 90yrs
Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house intensive care unit
Age > 18yrs and < 90yrs

Exclusion Criteria

Patent foramen ovale
Cardial pathology (valvular heart disease, prosthesis, endocarditis)
Neurocognitive disturbances
...
Patent foramen ovale
Cardial pathology (valvular heart disease, prosthesis, endocarditis)
Neurocognitive disturbances
Preexistent neurological morbidity
Carotid artery stenosis > 70%
Treatment with other extracorporeal devices
Absent informed consent
Inclusion in an other clinical study
Allergy against materials of the medical device used in the study (transcranial Doppler) or temporal skin/bone lesions
Pregnancy, drug abuse

Summary

Conditions
  • Cerebral Embolism
  • Complication of Dialysis
  • Thrombus Due to Renal Dialysis Device, Implant, or Graft
Type
Observational
Design
  • Observational Model: Case-Only
  • Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 90 years
Gender
Both males and females

Inclusion Criteria

Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house intensive care unit
Age > 18yrs and < 90yrs
Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house intensive care unit
Age > 18yrs and < 90yrs

Exclusion Criteria

Patent foramen ovale
Cardial pathology (valvular heart disease, prosthesis, endocarditis)
Neurocognitive disturbances
...
Patent foramen ovale
Cardial pathology (valvular heart disease, prosthesis, endocarditis)
Neurocognitive disturbances
Preexistent neurological morbidity
Carotid artery stenosis > 70%
Treatment with other extracorporeal devices
Absent informed consent
Inclusion in an other clinical study
Allergy against materials of the medical device used in the study (transcranial Doppler) or temporal skin/bone lesions
Pregnancy, drug abuse

Tracking Information

NCT #
NCT02021045
Collaborators
Not Provided
Investigators
  • Principal Investigator: Gabor Erdoes, MD Medical University of Vienna
  • Gabor Erdoes, MD Medical University of Vienna